These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2858083)

  • 1. Anxiety, anxiolytics and brain stimulation reinforcement.
    Liebman JM
    Neurosci Biobehav Rev; 1985; 9(1):75-86. PubMed ID: 2858083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of the pyrazolo-type compounds: agonist, antagonist and inverse agonist actions.
    Bennett DA
    Physiol Behav; 1987; 41(3):241-5. PubMed ID: 2893398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA(A)-receptor subtypes: a new pharmacology.
    Möhler H; Crestani F; Rudolph U
    Curr Opin Pharmacol; 2001 Feb; 1(1):22-5. PubMed ID: 11712530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of anxiolytic drugs on rewarding and aversive behaviors induced by intracranial stimulation].
    Gomita Y; Moriyama M; Ichimaru Y; Araki H; Sagara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Jun; 24(3):111-8. PubMed ID: 15291239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinic prediction of the spectrum of psychotropic activity of tranquilizers.
    Valdman AV
    Pharmacol Res Commun; 1980 Mar; 12(3):255-66. PubMed ID: 6104824
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
    Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
    Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anxiolytic drugs on rewarding and aversive behaviors induced by intracranial stimulation.
    Gomita Y; Ichimaru Y; Moriyama M; Araki H; Futagami K
    Acta Med Okayama; 2003 Jun; 57(3):95-108. PubMed ID: 12908007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in the pharmacology of hypnotics and anxiolytics].
    Scuvée-Moreau J; Seutin V
    Rev Med Liege; 2001 Mar; 56(3):159-64. PubMed ID: 11338787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is tofisopam an atypical anxiolytic?
    Pellow S; File SE
    Neurosci Biobehav Rev; 1986; 10(2):221-7. PubMed ID: 2874535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing action.
    Lloyd KG; Depoortere H; Scatton B; Schoemaker H; Zivkovic B; Manoury P; Langer SZ; Morselli PL; Bartholini G
    Pharmacol Biochem Behav; 1985 Oct; 23(4):645-52. PubMed ID: 2866545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of GABA agonists in relation to anxiety and benzodiazepine action.
    Shephard RA
    Life Sci; 1987 Jun; 40(25):2429-36. PubMed ID: 2884549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auto-titration technique using intracranial self-stimulation and effects of antianxiety drugs.
    Ichimaru Y; Moriyama M; Gomita Y
    Jpn J Pharmacol; 1985 Nov; 39(3):331-8. PubMed ID: 2869166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and pharmacologic study of 1,5-benzodiazepine-2,4-diones and their alkyl derivatives].
    Zellou A; Cherrah Y; Hassar M; Essassi EM
    Ann Pharm Fr; 1998; 56(4):169-74. PubMed ID: 9770010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
    McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinforcing versus anticonvulsant drugs: effects on intracranial self-stimulation rate-frequency M50 indices.
    Bossert JM; Franklin KB
    Behav Brain Res; 2003 Sep; 144(1-2):243-7. PubMed ID: 12946613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can drug effects on anxiety and convulsions be separated?
    Pellow S
    Neurosci Biobehav Rev; 1985; 9(1):55-73. PubMed ID: 2858082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the action of tranquilizers on reinforcement systems].
    Marusov IV
    Farmakol Toksikol; 1979; 42(3):203-8. PubMed ID: 36295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.